SATVI 2024 Annual Report now available

We are pleased to present the 2024 Annual report which outlines various significant advances SATVI has made across TB vaccine development, diagnostic innovation, and translational research that continue to drive meaningful progress toward addressing the global burden of TB.

To read in flipbook mode online. Click here